2658-6533Научные результаты биомедицинских исследований2658-653310.18413/2658-6533-2022-8-2-0-12716Генетика<strong>Association of polymorphism rs10841855&nbsp;</strong><strong>in the glycogen synthase 2 gene with hypercholesterolemia and type 2 diabetes mellitus</strong><strong>Association of polymorphism rs10841855&nbsp;</strong><strong>in the glycogen synthase 2 gene with hypercholesterolemia and type 2 diabetes mellitus</strong>AzarovaIuliia E.AzarovaIuliia E.azzzzar@yandex.ruKorvyakovaYaroslava E.KorvyakovaYaroslava E.yasya_kursk@mail.ruGlotovAlexander O.GlotovAlexander O.aoglotoff@yandex.ruIvakinVladimir E.IvakinVladimir E.ivakinve@kursksmu.netPolonikovAlexey V.PolonikovAlexey V.polonikov@rambler.ru20228200

Background:&nbsp;Glycogen synthase 2 (GYS2) catalyzes a key step in glycogenesis in the liver. Loss-of-function mutations in the GYS2 gene are associated with type 0a glycogenosis with characteristic fasting hypoglycemia and postprandial hyperglycemia. The association of the single nucleotide polymorphism rs10841855 (G&gt;T) with the risk of type 2 diabetes mellitus (T2D) was first established in the European population, but data on the effect of this variant on the predisposition to T2D in the inhabitants of the Slavic ethnic group of Central Russia are not available in the literature. The aim of the study:&nbsp;To investigate the association of polymorphism rs10841855 (G&gt;T) GYS2 with the risk of T2D in residents of Central Russia. Materials and methods:&nbsp;The study included 2668 unrelated individuals of Slavic origin, including 1387 patients with T2D and 1281 healthy volunteers. Genotyping of the rs10841855 polymorphism of the GYS2 gene was performed by the MassArray Analyzer-4 genetic analyzer. SNPStats software was used for statistical analysis of the data. Results:&nbsp;Linear regression established an association of the alternative rs10841855-T allele (OR 1.25; 95% CI 1.09-1.43; P=0.001) and the rs10841855-G/T genotype (OR 1.37; 95% CI 1, 13-1.66; P=0.0064) of GYS2 with an increased risk of T2D. The sex- and BMI-stratified analysis showed that the association of the rs10841855-G/T genotype (OR 1.71; 95% CI 1.32-2.22; P=0.0001) occurred only in females with BMI&gt;25 kg/m2. In addition, carriage of the rs10841855-T allele was associated with a higher level of total cholesterol in the blood plasma of T2D patients (P=0.0068). According to the Roadmap Epigenomic Consortium, the rs10841855-T allele is associated with H3K4 histone methylation in the enhancer and promoter regions of the GYS2 gene in the liver. Conclusion:&nbsp;The association of rs10841855 of the GYS2 gene with an increased risk of T2D in residents of Central Russia was validated for the first time. The association may be explained by the low transcriptional activity of the glycogen synthase 2 gene in the carriers of the alternative allele of this polymorphism.

Background:&nbsp;Glycogen synthase 2 (GYS2) catalyzes a key step in glycogenesis in the liver. Loss-of-function mutations in the GYS2 gene are associated with type 0a glycogenosis with characteristic fasting hypoglycemia and postprandial hyperglycemia. The association of the single nucleotide polymorphism rs10841855 (G&gt;T) with the risk of type 2 diabetes mellitus (T2D) was first established in the European population, but data on the effect of this variant on the predisposition to T2D in the inhabitants of the Slavic ethnic group of Central Russia are not available in the literature. The aim of the study:&nbsp;To investigate the association of polymorphism rs10841855 (G&gt;T) GYS2 with the risk of T2D in residents of Central Russia. Materials and methods:&nbsp;The study included 2668 unrelated individuals of Slavic origin, including 1387 patients with T2D and 1281 healthy volunteers. Genotyping of the rs10841855 polymorphism of the GYS2 gene was performed by the MassArray Analyzer-4 genetic analyzer. SNPStats software was used for statistical analysis of the data. Results:&nbsp;Linear regression established an association of the alternative rs10841855-T allele (OR 1.25; 95% CI 1.09-1.43; P=0.001) and the rs10841855-G/T genotype (OR 1.37; 95% CI 1, 13-1.66; P=0.0064) of GYS2 with an increased risk of T2D. The sex- and BMI-stratified analysis showed that the association of the rs10841855-G/T genotype (OR 1.71; 95% CI 1.32-2.22; P=0.0001) occurred only in females with BMI&gt;25 kg/m2. In addition, carriage of the rs10841855-T allele was associated with a higher level of total cholesterol in the blood plasma of T2D patients (P=0.0068). According to the Roadmap Epigenomic Consortium, the rs10841855-T allele is associated with H3K4 histone methylation in the enhancer and promoter regions of the GYS2 gene in the liver. Conclusion:&nbsp;The association of rs10841855 of the GYS2 gene with an increased risk of T2D in residents of Central Russia was validated for the first time. The association may be explained by the low transcriptional activity of the glycogen synthase 2 gene in the carriers of the alternative allele of this polymorphism.

type 2 diabetes mellitussingle nucleotide polymorphismGYS2glycogen synthasegenetic predispositiontype 2 diabetes mellitussingle nucleotide polymorphismGYS2glycogen synthasegenetic predispositionСписок литературыSun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.&nbsp;Diabetes Research and Clinical Practice. 2022;183:109119. DOI: https://doi.org/10.1016/j.diabres.2021.109119DeFronzo RA. Pathogenesis of Type 2 Diabetes Mellitus. In: Bonora E, DeFronzo R, editors. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Endocrinology. Springer, Cham; 2018:1-74. DOI: https://doi.org/10.1007/978-3-319-27317-4_8-1Skovs&oslash; S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. Journal of Diabetes Investigation. 2014;5(4):349-358. DOI: https://doi.org/10.1111/jdi.12235Malik VS, Hu FB. Sweeteners and risk of obesity and type 2 diabetes: the role of sugar-sweetened beverages. Current Diabetes Reports. 2012;12(2):195-203. DOI: https://doi.org/10.1007/s11892-012-0259-6Li DD, Yang Y, Gao ZY, et al. Sedentary lifestyle and body composition in type 2 diabetes. Diabetology and Metabolic Syndrome. 2022;14(1):1-11. DOI: https://doi.org/10.1186/s13098-021-00778-6Bertoglia MP, Gormaz JG, Libuy M, et al. The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010.&nbsp;PLoS ONE. 2017;12(5):e0178092. DOI: https://doi.org/10.1371/journal.pone.0178092Hackett RA, Steptoe A. Type 2 diabetes mellitus and psychological stress&mdash;a modifiable risk factor. Nature Reviews Endocrinology. 2017;13(9):547-560. DOI: https://doi.org/10.1038/nrendo.2017.64World Health Organization. Global report on diabetes: executive summary (No. WHO/NMH/NVI/16.3). World Health Organization; 2016.Scott RA, Scott LJ, M&auml;gi R, et al. An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes. 2017;66(11):2888-2902. DOI: https://doi.org/10.2337/db16-1253Orho M, Bosshard NU, Buist NRM, et al. Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. Journal of Clinical Investigation. 1998;102:507-515. DOI: https://doi.org/10.1172/JCI2890Iijima H, Ago Y, Fujiki R, et al. Novel GYS2 mutations in a Japanese patient with glycogen storage disease type 0a. Molecular Genetics and Metabolism Reports. 2021;26:100702. DOI: https://doi.org/10.1016/j.ymgmr.2020.100702Dedov II, Zubkova NA, Arbatskaya NYu, et al. MODY2: Clinical and molecular genetic characteristics of 13 cases of the disease. The first description of MODY in Russia. Problems of Endocrinology. 2009;55(3):3-7. Russian. DOI: https://doi.org/10.14341/probl20095533-7Azarova I, Bushueva O, Konoplya A, et al. Glutathione S-transferase genes and the risk of type 2 diabetes mellitus: Role of sexual dimorphism, gene&ndash;gene and gene&ndash;smoking interactions in disease susceptibility. Journal of Diabetes. 2018;10(5):398-407. DOI: https://doi.org/10.1111/1753-0407.12623Azarova IE, Klyosova EYu, Samgina TA, et al. Role of cyba gene polymorphisms in pathogenesis of type 2 diabetes mellitus. Medical Genetics. 2019;18(8):37-48. Russian. DOI: https://doi.org/10.25557/2073-7998.2019.08.37-48Azarova IE, Klyosova EYu, Sakali SYu, et al. Contribution of rs11927381 polymorphism of the IGF2BP2 gene to the pathogenesis of type 2 diabetes. Research Results in Biomedicine. 2020;6(1):9-19. Russian. DOI: https://doi.org/10.18413/2658-6533-2020-6-1-0-2Adeva-Andany MM, Gonz&aacute;lez-Luc&aacute;n M, Donapetry-Garc&iacute;a C, et al. Glycogen metabolism in humans. BBA Clinical. 2016;5:85-100. DOI: https://doi.org/10.1016/j.bbacli.2016.02.001Zhang H, Ma J, Tang K, et al. Beyond energy storage: roles of glycogen metabolism in health and disease. FEBS Journal. 2021;288(12):3772-3783. DOI: https://doi.org/10.1111/febs.15648Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nature Reviews Endocrinology. 2017;13(10):572-587. DOI: https://doi.org/10.1038/nrendo.2017.80Pederson BA. Mammalian Glycogen Metabolism Enzymology, Regulation, and Animal Models of Dysregulated Glycogen Metabolism.&nbsp;Enzymology of Complex Alpha-Glucans.&nbsp;CRC Press; 2021:84-137.Lewis GF, Carpentier AC, Pereira S, et al. Direct and indirect control of hepatic glucose production by insulin. Cell Metabolism. 2021;33(4):709-720. DOI: https://doi.org/10.1016/j.cmet.2021.03.007Kanai M, Akiyama M, Takahashi A, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nature Genetics. 2018;50(3):390-400. DOI: https://doi.org/10.1038/s41588-018-0047-6L&oacute;pez-Soldado I, Guinovart JJ, Duran J. Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice. Journal of Biological Chemistry. 2021;296:100498. DOI: https://doi.org/10.1016/j.jbc.2021.100498Chen J, Spracklen CN, Marenne G, et al. The trans-ancestral genomic architecture of glycemic traits. Nature Genetics. 2021;53(6):840-860. DOI: https://doi.org/10.1038/s41588-021-00852-9Hwang JY, Lee EJ, Jin Go M, et al. Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. Journal of Human Genetics. 2012;57(10):660-664. DOI: https://doi.org/10.1038/jhg.2012.92Sharifi-Zarchi A, Gerovska D, Adachi K, et al. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism. BMC Genomics. 2017;18(1):1-21. DOI: https://doi.org/10.1186/s12864-017-4353-7Oh KJ, Han HS, Kim MJ, et al. CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. BMB Reports. 2013;46(12):567. DOI: https://doi.org/10.5483/BMBRep.2013.46.12.248Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1&ndash;PGC-1&alpha; interaction. Nature. 2003;423(6939):550-555. DOI: https://doi.org/10.1038/nature01667Chernikova NA, Kamynina LL, Ametov AS, et al. The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus. Therapeutic archive. 2020;24;92(10):54-62. Russian. DOI: https://doi.org/10.26442/00403660.2020.10.000530